In previous studies we have shown that in HepG2 cells, as compared with fibroblasts, the low-density lipoprotein (LDL) receptor is only weakly down-regulated upon incubation of the cells with LDL. To explain this difference in down-regulation of the LDL-receptor activity, we studied simultaneously the intracellular processing of 125I-labelled LDL in both cell lines. Upon incubation of HepG2 cells with 125I-LDL, the appearance of degradation products started at 90 min, whereas in fibroblasts this lag time was only 30 min. The degradation efficiency (representing the ratio degradation/cell association of LDL) in HepG2 was less than 50 % of that in fibroblasts up to 5 h of incubation at 37 'C. The longer lag time and low efficiency of the degradation of LDL in HepG2 cells were independent of the cell density. Pulse-chase experiments indicated that the internalization rate of surface-bound LDL in HepG2 cells is similar to that offibroblasts. Endosomal loading of 125I-LDL by incubation INTRODUCTION
INTRODUCTION
It has been widely demonstrated that the liver is the major site of removal of low-density lipoproteins (LDL) from the circulation, accounting for about 80 % of the total LDL catabolism [1] . Up to 700% of LDL is cleared from the plasma via high-affinity binding to receptors gathered in coated pits on the plasma membrane. After binding, the coated pits invaginate, after which endosomes are formed and, upon acidification, the LDL dissociates from the receptor. The receptor returns to the surface, binds another lipoprotein particle and initiates another cycle of endocytosis. After dissociation from the receptor, LDL is delivered to the lysosomes, where the protein component of LDL is hydrolysed to amino acids. The cholesterol released from the degraded LDL leads to a decrease in the cholesterol biosynthesis de novo, activates the esterification of cholesterol to cholesteryl esters and suppresses the synthesis of LDL receptors de novo by blocking gene expression. These co-ordinated actions allow the cells to be provided with sufficient cholesterol for metabolic needs without causing over-accumulation of free cholesterol (for review, see [2] ).
To study the regulation of LDL-receptor activity and cellular cholesterol homoeostasis, HepG2 cells are often used as a model for human hepatocytes [3] [4] [5] . HepG2 cells have been shown to possess functional LDL receptors with properties similar to those of human fibroblasts [3] . Previous studies performed in our laboratory have shown that the LDL receptors in both HepG2 cells and freshly isolated human hepatocytes are much less responsive to down-regulation by extracellular LDL than are LDL receptors in fibroblasts [6, 7] . In addition, the LDL-receptor activity in HepG2 cells and human hepatocytes was found to be at 18°C for 4.5 h, followed by a shift to 37°C, resulted in degradation of LDL within 30 min in fibroblasts, whereas in HepG2 cells the lag time of the degradation was 90 min. In parallel experiments using subcellular fractionation by Percollgradient centrifugation of homogenized cells and 1251-tyraminecellobiose-labelled LDL, we observed that in both cell types LDL is equally rapidly shifted from a low-to a high-density compartment (within 15 
Lipoproteins
LDL was isolated from serum of normolipidaemic donors by density-gradient ultracentrifugation as described by Redgrave et al. [9] . LDL was immediately labelled with 1251 as described by Bilheimer et al. [10] . The specific radioactivity ranged from 100 to 150 c.p.m./ng of LDL protein. After iodination, the LDL sample was dialysed against phosphate-buffered saline (PBS, pH 7.4) and stabilized with 1 % (w/v) HSA [3] . The stabilized 125I-labelled LDL was stored at 4°C and used within 2 weeks. Less than 1 % of the radioactivity was soluble in 10% (w/v) trichloroacetic acid. For '251-tyramine-cellobiose (TC) labelling, LDL was first dialysed exhaustively against PBS/0.01 % (w/v) EDTA. The labelling was then performed exactly as described by Pittman and Taylor [11] . 1251-TC-LDL (specific activity in the range 60-80 c.p.m./ng) was stabilized as above and used within 2 weeks. Whenever unlabelled LDL was used, it was immediately stabilized after isolation with 1 % HSA, followed by extensive dialysis against PBS and subsequently DMEM supplemented with penicillin (100 units/ml) and streptomycin (100 ,ug/ml).
Lipoprotein-depleted serum (LPDS) was obtained by ultracentrifugation of serum at a density of 1.21 g/ml, followed by extensive dialysis ofthe infranatant against PBS and subsequently DMEM supplemented with penicillin and streptomycin.
Cell culture
HepG2 cells and fibroblasts were cultured in flasks in DMEM supplemented with 10% (v/v) heat-inactivated FCS, 20 mM Hepes, 10 mM NaHCO3, 100 units/ml penicillin and 100 ,ug/ml streptomycin at 37°C in equilibration with air/CO2 Figure legends . After the incubation with labelled LDL, cells were cooled to 0 'C. Degradation of LDL was measured exactly as described in [12] . After removal of the incubation medium, the cells were washed extensively as described in [13] . To measure total cell association, the washed cells were dissolved in 0.2 M NaOH, and a portion of the cell lysate was counted for radioactivity. Another portion of the cell lysate was used for protein determination as described by
Lowry et al. [14] .
When the internalization of 1251-LDL was measured, cells were 0.02 % (w/v) EDTA in PBS for 10 min at room temperature [15] . The radioactivity released into the buffer represents the amount of 1251-LDL bound to the cell membrane. The radioactivity which remains cell-associated represents the amount of 125I-LDL internalized.
Values for the specific (receptor-mediated) binding, internalization and degradation were calculated by subtracting the amount oflabelled LDL that was bound, internalized or degraded in the presence of a 50-fold excess of unlabelled LDL (nonspecific binding) from the amount of labelled LDL that was bound, internalized or degraded in the absence of excess unlabelled LDL (total binding).
Subcellular fractionation using Percoll
HepG2 cells and fibroblasts were subcellularly fractionated on Percoll density gradients as previously described [16] Influence of the cell density on cell association and degradation of '251-LDL in HepG2 cells
In fibroblast cultures it has been shown that the LDL-receptor activity decreases with an increase in cell density [18] . We wondered whether the same correlation holds true for the expression of the LDL receptor in HepG2 cells and whether this could explain the observed delay and relatively low efficiency of the degradation of LDL in HepG2 cells. As for fibroblasts, with HepG2 cells both the cell association and degradation were higher at lower cell densities, on the basis of cell protein ( Figure  2a) . The degradation started after a lag period of about 90 min, irrespective of the cell density. The calculated degradation efficiency appeared thus to be independent of the cell density ( Figure 2b) . As a next step, we investigated whether the decreased degradation efficiency of LDL in HepG2 cells could be due to (i) a decreased internalization rate of surface-bound LDL, (ii) a delayed and less efficient transport of LDL from the earlyendosomal to the late-endosomal or lysosomal compartment, or (iii) a less efficient degradation of LDL in the lysosomes itself.
Rate of internalization of surface-bound 1251-LDL in fibroblasts and HepG2 cells The rate of internalization of '25l-LDL was examined by first incubating HepG2 cells and fibroblasts at 4°C with 10 ,ug/ml l25l-LDL for 2 h, to allow binding of LDL to its cell surface receptors. Thereafter, the cells was washed and further incubated at 37 'C. As shown in Figure 3 , most of the cell-bound LDL is already internalized within 5 min, whereas the maximal internalization is reached within [15] [16] [17] [18] [19] [20] [19] and to a block in endosome-lysosome fusion [20]. As a result, the cell-associated lipoproteins will accumulate in the early-endosomal compartment at this temperature.
In a time-course experiment at 18°C, we verified that in both fibroblasts and HepG2 cells indeed no detectable degradation of LDL occurred during the 4.5 h of incubation at 18°C ( Figure  4a ). After that time the cells were washed in order to remove the unbound ligand and further incubated at 37°C (Figure 4b ). After the temperature shift to 37°C, in fibroblasts we observed a lag period of 30 min followed by a rapid appearance of degradation products into the medium. In HepG2 cells this lag period was about 90 min and the degradation of LDL appeared to occur at a slower rate than in fibroblasts.
In a parallel experiment, the incubation for 4.5 h at 18°C was carried out in the presence of 1251-TC-LDL, after which the temperature was shifted to 37°C and, at the indicated time points, cells were homogenized. The subcellular fractionation of cell homogenates shows ( Figure 5 , time 0 at 37°C) that, owing to their lower buoyant density, the early endosomes were separated from the lysosomes by Percoll-gradient centrifugation [16] . The late endosomes, having a density similar to that of the lysosomes [21] , are recovered with the high-density fractions. As shown in Figure 5 , at zero time all the label was found in the early-endosomal (light) fractions, whereas after 30 min of incubation at 37°C most of the label was found in the bottom fractions of the gradient. That these fractions contain lysosomal activity has been tested by measuring acid phosphatase activity as lysosomal marker [22] .
As shown in Figure 6 , for both cell lines at zero time only 
DISCUSSION
Several studies have shown that HepG2 cells possess functional LDL receptors with properties similar to those of human fibroblasts [3] . However, some aspects of the mechanism regulating the LDL-receptor activity in both HepG2 cells and primary cultures of human hepatocytes are likely to differ from those that have been characterized in fibroblasts and in cells derived from other peripheral tissues [2] . In this respect, we have demonstrated that both HepG2 cells [6] and freshly isolated human hepatocytes [7] are much less responsive to feedback regulation by LDL than are fibroblasts. In these studies it also appeared that the LDLreceptor activity in HepG2 cells and human hepatocytes was stimulated 2-3-fold by the presence of cholesterol acceptors such as heavy HDL, whereas in fibroblasts the LDL-receptor activity was almost insensitive to the presence of heavy HDL. Studies on the cellular cholesterol homoeostasis in relation to the LDLreceptor activity in HepG2 cells suggested that both the exogenously delivered (LDL) cholesterol and the endogenously synthesized cholesterol are primarily directed to a cholesteryl ester pool or, if present, to extracellular cholesterol acceptors, like heavy HDL, rather than to the regulatory free cholesterol pool involved in the regulation of the LDL-receptor activity [8] .
In the present work we compared the processing of LDL in HepG2 cells and fibroblasts in more detail, reasoning that information about this pathway might help to explain the marked difference between the two cell lines in their ability to modulate the LDL-receptor activity in response to the presence of exogenous cholesterol.
Data reported in the literature [23, 24] Our results show that the degradation of LDL in HepG2 cells appears to be severely impaired, being not only delayed but also inefficient, as expressed by the low ratio of degradation/cell association (Figures 1 and 2) . A number of other studies concur with our findings of a relatively inefficient degradation of LDL in HepG2 cells. Edge et al. [25] also found that the binding and uptake of LDL in cultured human hepatocytes was similar to that seen in fibroblasts, whereas the degradation efficiency of LDL was lower than in fibroblasts. Kamps et al. [26] showed that in human parenchymal liver cells the LDL uptake is also not efficiently coupled to catabolism.
In our attempt to delineate the events responsible for the observed defect in the degradation of LDL in HepG2 cells, we measured the rate of distribution of LDL between the endosomes and the lysosomes in both cell lines. In these experiments cells were incubated at 18°C, since at this temperature no ligandreceptor dissociation and no fusion between endocytic vesicles and lysosomes occurs, and the ligand thus accumulates in the early-endosomal compartment [20] . When this approach was used, the difference in LDL degradation between fibroblasts and HepG2 cells was still apparent (Figure 4) . Subsequently, the distribution of LDL between the endosomes and the lysosomes was measured with 1251-TC-LDL. Upon degradation of proteins, 1251-TC remains attached to short peptide fragments, and in this form no release of label from the lysosomes occurs [27] . Using this experimental design, we did not observe any difference between both cell lines in the processing of LDL from the earlyendosomal compartment to the late-endosomal or lysosomal compartment. This indicates that the dissociation of LDL from the receptor does not represent a rate-limiting step in the degradation of LDL. The method for subcellular fractionation used does not enable us to discriminate further between a prelysosomal and the lysosomal compartment. Therefore from our data we can conclude that in HepG2 cells either the fusion process between the late endosomes and the lysosomes is altered, or the degradation of LDL itself in the lysosomes is less efficient than in fibroblasts.
Several studies in fibroblasts [18] , smooth-muscle cells [28] , endothelial cells [29] , A431 cells [30] and rat hepatocytes [31] have shown that the LDL-receptor activity decreases with increasing cell densities. Our results with HepG2 cells confirm this inverse correlation between cell density and LDL-receptor activity (Figure 2) . However, the lag period and the efficiency of the degradation, expressed as the ratio degradation/cell association, was not influenced by the cell density (Figure 2) .
The absence of a relationship between LDL-receptor activity and degradation efficiency is sustained by our previous observation that the stimulation of the LDL receptor in HepG2 cells by incubation with heavy HDL does not result in an increased efficiency of LDL degradation [6] . Similarly, ursodeoxycholic acid was found to enhance receptor-dependent LDL uptake to a similar extent to the degradation in isolated hamster hepatocytes [32] .
A primarily direction of exogenously delivered LDL cholesterol and endogenously synthesized cholesterol to an intracellular cholesteryl ester pool or to extracellular cholesterol acceptors rather than to the regulatory free cholesterol pool involved in LDL-receptor activity has been reported [8] . With the present results, we argue that also a relatively low degradation efficiency of LDL in HepG2 cells may contribute to provide an explanation for the relatively weak down-regulation of the LDLreceptor activity in HepG2 cells on incubation of the cells with LDL.
